- ICH GCP
- EU Clinical Trials Registry
Latest Trials
EudraCT Number: 2007-007931-25 | Sponsor Protocol Number: 158/06 | Start Date: 2006-11-18 | |||||||||||
Sponsor Name: AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: Prospective evaluation on the role exerted by the association of ethinylestradiol (0,03 mg) plus clormadinone acetate (2 mg) or ethinylestradiol (0,02 mg) plus desogestrel (0,15 mg) on insulin sens... | |||||||||||||
Medical condition: Volontari sani | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005766-36 | Sponsor Protocol Number: | Start Date: 2006-11-17 | ||||||
Sponsor Name: Sofamor - Danek | ||||||||
Full Title: A Randomized Prospective Study of Instrumented Posterior Lumbar Interbody Fusion: Autologous Iliac Crest Bone Graft vs. Inductos™ | ||||||||
Medical condition: We will investigate if the use of Inductos in a intervertebral cage will provide us with better and or faster fusion rates. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: BE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001489-17 | Sponsor Protocol Number: SIOPENRNET003 | Start Date: 2006-11-17 | ||||||
Sponsor Name: St. Anna Kinderkrebsforschung e.V. | ||||||||
Full Title: High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN) | ||||||||
Medical condition: High Risk Neuroblastoma | ||||||||
|
||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||
Trial protocol: AT (Ongoing) ES (Restarted) GB (GB - no longer in EU/EEA) BE (Ongoing) DK (Restarted) IE (Ongoing) HU (Ongoing) FI (Ongoing) SI (Completed) PL (Ongoing) GR (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005087-93 | Sponsor Protocol Number: | Start Date: 2006-11-17 | ||||||
Sponsor Name: East Kent Hospitals NHS Trust | ||||||||
Full Title: A randomized double blind placebo controlled trial of Memantine in the treatment of Agitation in Alzheimers Dementia | ||||||||
Medical condition: Alzheimers dementia | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004041-42 | Sponsor Protocol Number: 108251, 108252, 111275, 111276 | Start Date: 2006-11-17 | ||||||
Sponsor Name: GlaxoSmithKline Biologicals | ||||||||
Full Title: A phase II, randomised, open study to evaluate the immunogenicity and safety of a single or double-dose of the pandemic influenza candidate vaccine (split virus formulation adjuvanted with AS03) gi... | ||||||||
Medical condition: Immunization against influenza disease during pandemic in subjects over 60 years of age. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: BE (Completed) IT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-002553-80 | Sponsor Protocol Number: ADHD Norrtälje 2006 | Start Date: 2006-11-17 | ||||||
Sponsor Name: Karolinska Universitetssjukhuset | ||||||||
Full Title: ADHD hos intagna inom Kriminalvården - förekomst/diagnos/behandling/uppföljning | ||||||||
Medical condition: Attention Deficit Hyperactivity Disorder (ADHD) | ||||||||
|
||||||||
Population Age: Adults | Gender: Male | |||||||
Trial protocol: SE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002938-38 | Sponsor Protocol Number: MHH – EPONTX – 01/06 | Start Date: 2006-11-17 | ||||||
Sponsor Name: Hannover Medical School | ||||||||
Full Title: EFFECT OF ERYTHROPOIETIN ON RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION | ||||||||
Medical condition: We will investigate the effect of recombinant human erythropoietin (rHuEPO) on ischemia-reperfusion injury in patients with terminal renal failure undergoing cadaveric kidney transplantation. In th... | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-002633-20 | Sponsor Protocol Number: A4M105038 | Start Date: 2006-11-17 | |||||||||||
Sponsor Name: GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months' Administration of Firategrast (150 – 1200mg twice dail... | |||||||||||||
Medical condition: Relapsing-Remitting Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) FI (Completed) FR (Completed) AT (Completed) IT (Completed) LT (Prematurely Ended) GB (Completed) ES (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005470-41 | Sponsor Protocol Number: CTR0028 | Start Date: 2006-11-16 | ||||||
Sponsor Name: Regent Medical | ||||||||
Full Title: Hibiscrub EN12791 Testing using current application and 2 new application methods | ||||||||
Medical condition: This trial will be carried out on healthy volunteers. Hibiscrub is a 4% chlorhexidine glucnate based pre-operative surgical hand disinfectant. Volunteers are going to use the product in three dif... | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-004164-31 | Sponsor Protocol Number: protocole ISOROS | Start Date: 2006-11-16 | ||||||
Sponsor Name: Laboratoires BIORGA | ||||||||
Full Title: Evaluation de l'efficacité de l'isotrétinoïne versus placebo à travers le taux de patients répondeurs chez des patients présentant une rosacée papulo-pustuleuse résistant au traitement classique. E... | ||||||||
Medical condition: Rosacée papulo-pustuleuse résistant à un traitement classique | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FR (Ongoing) | ||||||||
Trial results: (No results available) |